Non-Surgical Aesthetic Devices Market

Executive Summary

Non-Surgical Aesthetic Devices Market was valued at US $49.65 billion in 2021 and is projected to grow at 13.18% CAGR over the forecast period to reach US $104.34 billion by 2027. Non-Surgical Aesthetic Devices Market represented US $10.89 billion opportunity over 2019-2021 and estimated to create US $54.69 billion opportunity in 2027 over 2021.

Non-Surgical Aesthetic Devices from Consainsights analyses the Non-Surgical Aesthetic Devices Market in the Life Sciences industry over the forecast period to 2027.

Non-Surgical Aesthetic Devices research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.

Non-Surgical Aesthetic Devices segmentation includes Type, Application, End-User and Geography.

Based on the Type, the Non-Surgical Aesthetic Devices analysis covers Laser-based Aesthetic Device, Radiofrequency (RF) Based Aesthetic Device, Ultrasound Aesthetic Device, Intense Pulsed Light Device, Others.

In Type segment, Laser-based Aesthetic Device segment has highest cagr growth of 11.63%.

Based on the Application, the Non-Surgical Aesthetic Devices analysis covers Skin Resurfacing and Tightening, Body Contouring and Cellulite Reduction, Hair Removal, Tattoo Removal, Others.

In Application segment, Skin Resurfacing and Tightening segment has highest cagr growth of 11.63%.

Based on the End-User, the Non-Surgical Aesthetic Devices analysis covers Hospital, Beauty Clinics, Others.

In End-User segment, Hospital segment has highest cagr growth of 11.63%.

Based on the region, the Non-Surgical Aesthetic Devices analysis covers North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America.

Key companies operating in the market include Fotona, Bausch & Lomb Incorporated ( Bausch Health), Alma Lasers, Lynton Lasers Ltd., Cutera Inc., STRATA Skin Sciences, Sciton, Inc., Lutronic, El.En. S.p.A., Lumenis and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.

Market Overview

Definition & Scope

The base currency considered was the US Dollar (USD). Conversion of other currencies to USD was considered on the basis of the average exchange rate for the respective review-period years. The exchange rate conversion for forecast period was determined according to the base year’s conversion rates.

The base year was identified based on the availability of annual reports and secondary information. The base year considered for this study is 2027.

The review period considered for this study is from 2018-2027. The CAGR is for the forecast period, 2022-2027.

Market size estimations for the forecast years were in real terms. Inflation is not part of the pricing, and the average selling price (ASP) was kept constant throughout the forecast period for each country.

Distribution of primary interviews conducted was based on the regional share of the market and the presence of key players in each region.

As a result of data triangulation through multiple methodologies and approaches, the weighted averages of resulting estimates were considered to be the final values.

Currency, Year & Forecast

The currency used in this report is USD, with the market size indicated in terms of USD million/billion.

For companies reporting their revenues in USD, the revenues were taken from their respective annual reports/SEC filings.

For companies reporting their revenues in other currencies, the average annual currency conversion rates were used for a particular year to convert the value to USD Market Definition.

Type

Introduction

In 2021, Laser-based Aesthetic Device segment has the highest revenue of US $18.64 billion and is expected to grow at CAGR of 11.63% by 2027 Laser-based Aesthetic Device segment has highest cagr growth of 11.63%.

Laser-based Aesthetic Device

Laser-based Aesthetic Device segment was valued at US $14.55 billion in 2019 and is projected to grow at 11.63% CAGR over the forecast period to reach US $39.18 billion by 2027. Laser-based Aesthetic Device segment represented US $4.09 billion opportunity over 2019-2021 and estimated to create US $20.54 billion opportunity in 2027 over 2021.

Radiofrequency (RF) Based Aesthetic Device

Radiofrequency (RF) Based Aesthetic Device segment was valued at US $11.05 billion in 2019 and is projected to grow at 11.63% CAGR over the forecast period to reach US $29.73 billion by 2027. Radiofrequency (RF) Based Aesthetic Device segment represented US $3.10 billion opportunity over 2019-2021 and estimated to create US $15.59 billion opportunity in 2027 over 2021.

Ultrasound Aesthetic Device

Ultrasound Aesthetic Device segment was valued at US $7.29 billion in 2019 and is projected to grow at 11.63% CAGR over the forecast period to reach US $19.61 billion by 2027. Ultrasound Aesthetic Device segment represented US $2.05 billion opportunity over 2019-2021 and estimated to create US $10.28 billion opportunity in 2027 over 2021.

Intense Pulsed Light Device

Intense Pulsed Light Device segment was valued at US $3.96 billion in 2019 and is projected to grow at 11.63% CAGR over the forecast period to reach US $10.67 billion by 2027. Intense Pulsed Light Device segment represented US $1.11 billion opportunity over 2019-2021 and estimated to create US $5.59 billion opportunity in 2027 over 2021.

Others

Others segment was valued at US $1.91 billion in 2019 and is projected to grow at 11.63% CAGR over the forecast period to reach US $5.15 billion by 2027. Others segment represented US $0.54 billion opportunity over 2019-2021 and estimated to create US $2.70 billion opportunity in 2027 over 2021.

Application

Introduction

In 2021, Skin Resurfacing and Tightening segment has the highest revenue of US $20.58 billion and is expected to grow at CAGR of 11.63% by 2027 Skin Resurfacing and Tightening segment has highest cagr growth of 11.63%.

Skin Resurfacing and Tightening

Skin Resurfacing and Tightening segment was valued at US $16.07 billion in 2019 and is projected to grow at 11.63% CAGR over the forecast period to reach US $43.26 billion by 2027. Skin Resurfacing and Tightening segment represented US $4.51 billion opportunity over 2019-2021 and estimated to create US $22.67 billion opportunity in 2027 over 2021.

Body Contouring and Cellulite Reduction

Body Contouring and Cellulite Reduction segment was valued at US $8.63 billion in 2019 and is projected to grow at 11.63% CAGR over the forecast period to reach US $23.23 billion by 2027. Body Contouring and Cellulite Reduction segment represented US $2.42 billion opportunity over 2019-2021 and estimated to create US $12.18 billion opportunity in 2027 over 2021.

Hair Removal

Hair Removal segment was valued at US $7.41 billion in 2019 and is projected to grow at 11.63% CAGR over the forecast period to reach US $19.94 billion by 2027. Hair Removal segment represented US $2.08 billion opportunity over 2019-2021 and estimated to create US $10.45 billion opportunity in 2027 over 2021.

Tattoo Removal

Tattoo Removal segment was valued at US $3.60 billion in 2019 and is projected to grow at 11.63% CAGR over the forecast period to reach US $9.69 billion by 2027. Tattoo Removal segment represented US $1.01 billion opportunity over 2019-2021 and estimated to create US $5.08 billion opportunity in 2027 over 2021.

Others

Others segment was valued at US $3.06 billion in 2019 and is projected to grow at 11.63% CAGR over the forecast period to reach US $8.23 billion by 2027. Others segment represented US $0.86 billion opportunity over 2019-2021 and estimated to create US $4.31 billion opportunity in 2027 over 2021.

End-User

Introduction

In 2021, Hospital segment has the highest revenue of US $33.87 billion and is expected to grow at CAGR of 11.63% by 2027 Hospital segment has highest cagr growth of 11.63%.

Hospital

Hospital segment was valued at US $26.44 billion in 2019 and is projected to grow at 11.63% CAGR over the forecast period to reach US $71.17 billion by 2027. Hospital segment represented US $7.43 billion opportunity over 2019-2021 and estimated to create US $37.31 billion opportunity in 2027 over 2021.

Beauty Clinics

Beauty Clinics segment was valued at US $8.62 billion in 2019 and is projected to grow at 11.63% CAGR over the forecast period to reach US $23.21 billion by 2027. Beauty Clinics segment represented US $2.42 billion opportunity over 2019-2021 and estimated to create US $12.17 billion opportunity in 2027 over 2021.

Others

Others segment was valued at US $3.70 billion in 2019 and is projected to grow at 11.63% CAGR over the forecast period to reach US $9.96 billion by 2027. Others segment represented US $1.04 billion opportunity over 2019-2021 and estimated to create US $5.22 billion opportunity in 2027 over 2021.